As of September 30, 2026, Guangdong Lifestrong Pharmacy Co., Ltd. Class A carries a market capitalization of 3.41B, placing it among publicly traded companies globally. Its enterprise value stands at 3.09B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.41B |
| Enterprise Value | 3.09B |
As of September 30, 2026, Guangdong Lifestrong Pharmacy Co., Ltd. Class A has 160.00M shares outstanding.
| Shares Outstanding | 160.00M |
As of September 30, 2026, Guangdong Lifestrong Pharmacy Co., Ltd. Class A trades at a trailing price-to-earnings ratio of 512.76. The price-to-sales ratio is 11.41, and the price-to-book ratio stands at 4.57.
| PE Ratio | 512.76 |
| PS Ratio | 11.41 |
| PB Ratio | 4.57 |
| P/TBV Ratio | 4.80 |
As of September 30, 2026, Guangdong Lifestrong Pharmacy Co., Ltd. Class A trades at an EV/EBITDA multiple of 465.01 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 10.36 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 465.01 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 3.09B versus a market cap of 3.41B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 10.36 |
| EV / EBITDA | 465.01 |
| EV / EBIT | 465.01 |
As of September 30, 2026, Guangdong Lifestrong Pharmacy Co., Ltd. Class A maintains a current ratio of 7.07, meaning it holds 7.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 5.45, indicating elevated leverage, while an interest coverage ratio of 2.77 demonstrates limited ability to service its debt obligations.
| Current Ratio | 7.07 |
| Quick Ratio | 3.73 |
| Debt / Equity | 5.45 |
| Debt / EBITDA | 6.36 |
| Interest Coverage | 2.77 |
These figures cover the twelve months ended September 30, 2026. The company generates approximately 516,558.91 in revenue per employee across its workforce of 578.00, a quick read on workforce productivity versus industry peers.
| Revenue Per Employee | 516,558.91 |
| Employee Count | 578.00 |
Over the twelve months ended September 30, 2026, Guangdong Lifestrong Pharmacy Co., Ltd. Class A recorded 4.76M in income tax expense. That works out to an effective tax rate of 58.70, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 8.10M, leaving 6.64M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | 4.76M |
| Effective Tax Rate | 58.70 |
As of the close on November 17, 2026, Guangdong Lifestrong Pharmacy Co., Ltd. Class A's stock has declined approximately 11.99% over the past 52 weeks. The 50-day moving average sits at 19.73, while the 200-day moving average is 21.53.
| 52-Week Price Change | -11.99% |
| 50-Day Moving Average | 19.73 |
| 200-Day Moving Average | 21.53 |
Over the twelve months ended September 30, 2026, Guangdong Lifestrong Pharmacy Co., Ltd. Class A generated 298.57M in revenue and converted that into 6.64M in net income, yielding earnings per share of 0.02. EBITDA reached 6.65M, while operating income came in at -1.12M.
| Revenue | 298.57M |
| Gross Profit | 165.44M |
| Operating Income | -1.12M |
| Pretax Income | 8.10M |
| Net Income | 6.64M |
| EBITDA | 6.65M |
| EBIT | 6.65M |
| Earnings Per Share (EPS) | 0.02 |
As of September 30, 2026, Guangdong Lifestrong Pharmacy Co., Ltd. Class A holds 388.18M in cash and equivalents against 42.31M in total debt, resulting in a net debt position of -341.92M. Total book value stands at 745.70M, with working capital of 631.79M providing operational flexibility.
| Cash & Cash Equivalents | 388.18M |
| Total Debt | 42.31M |
| Net Debt | -341.92M |
| Equity (Book Value) | 745.70M |
| Book Value Per Share | 4.66 |
| Working Capital | 631.79M |
These figures cover the twelve months ended September 30, 2026.
| Capital Expenditures | -18.11M |
Over the twelve months ended September 30, 2026, Guangdong Lifestrong Pharmacy Co., Ltd. Class A posted a gross margin of 55.41, reflecting its pricing power and cost economics. The operating margin of -0.38 and net profit margin of 2.23 provide insight into operational efficiency.
| Gross Margin | 55.41 |
| Operating Margin | -0.38 |
| Pretax Margin | 2.71 |
| Profit Margin | 2.23 |
| EBITDA Margin | 2.23 |
Over the twelve months ended September 30, 2026, Guangdong Lifestrong Pharmacy Co., Ltd. Class A paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield is negative at -0.55, meaning Guangdong Lifestrong Pharmacy Co., Ltd. Class A raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -0.55 |
As of September 30, 2026, Guangdong Lifestrong Pharmacy Co., Ltd. Class A has an Altman Z-Score of 16.00, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 16.00 |
Already premium?